Related Experiment Videos
Another fork in the road: Foxo3a regulates NF-kappaB activation
Helen Su1, Nicolas Bidere, Michael Lenardo
1Molecular Development Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Immunity
|August 17, 2004
Summary
Transcription factor FoxO3a deficiency causes T cell hyperactivity and lymphoproliferative disease, contrary to expectations of apoptosis defects. This surprising finding links disease development to NF-kappaB hyperactivation in T cells.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Transcription factor FoxO3a has been previously linked to apoptosis induction.
- The role of FoxO3a in lymphoproliferative diseases has been unclear, with a potential link to cell death defects.
Purpose of the Study:
- To investigate the underlying mechanisms of lymphoproliferative disease in Foxo3a-deficient mice.
- To determine whether T cell hyperactivity or apoptosis defects contribute to disease development.
Main Methods:
- Analysis of Foxo3a-deficient mouse models.
- Assessment of T cell function and activation markers.
- Investigation of signaling pathways, including NF-kappaB, in T cells.
Main Results:
- Foxo3a deficiency leads to lymphoproliferative disease in mice.
- The disease is characterized by T cell hyperactivity, not defects in apoptosis.
- NF-kappaB hyperactivation in T cells is associated with disease development.
Conclusions:
- Contrary to previous assumptions, FoxO3a deficiency causes disease through T cell hyperactivity.
- NF-kappaB hyperactivation in T cells is a key driver of lymphoproliferative disease in the absence of FoxO3a.
- These findings reveal a novel role for FoxO3a in regulating T cell activation and preventing lymphoproliferation.